Breakthrough T1D CEO Aaron Kowalski, Ph.D., sits down for a conversation with Katie Beth Hand, a participant in the University of Chicago's clinical trial testing Eledon's tegoprubart.
Tegoprubart is used as an alternative to standard immunosuppressants to help prevent transplanted islet cells from rejection in people with type 1 diabetes.
Watch their full conversation about this exciting Breakthrough T1D-funded clinical trial here: https://t.co/MmOzySg2Ha
📍Middle Tennessee State Veteran’s Cemetery
This morning, cars lined the streets as hundreds of strangers gathered to honor Lonnie D. Wayman, a Navy veteran with no known family. What an incredible display of patriotism and true Volunteer spirit. God is good! 🇺🇸
@TicTacTitans Not looking the direction of Crosby once is probably a bad idea, but maybe this is a common thing. Honestly don’t know what to think about this team anymore. Nothing makes sense
I think PR is upset he left that open ended when asked about it yesterday and they scheduled this one for him to clarify that he is the play caller and will be moving forward. If they didn't trust him to call plays, which he was hired to do, they would have fired him by now and this would be a press conference for Borgonzi.